Clinical Data UCB reports positive outcomes for bimekizumab in psoriatic arthritis PharmaTimesTrial shows first headtohead superiority in joint endpoints for an approved PsA biologicImmunology & InflammationRead full story pharminent May 19, 2026 (Last updated: May 19, 2026) PharmaTimes Trial shows first headtohead superiority in joint endpoints for an approved PsA biologic Immunology & Inflammation Read full story Post navigation Previous: European study shows inequality in access to new medicinesNext: BioMarin suffers another blow to rare disease portfolio in Phase 3 flop Related Stories Clinical Data Novartis hit as Lp(a) drug fails cardio outcomes trial pharminent September 7, 2026 Clinical Data Major trial of Roche Alzheimer’s drug kicks off in Europe pharminent September 7, 2026 Clinical Data AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study pharminent September 4, 2026